Rave-Bio is developing a novel medical device with the potential to alleviate inflammation associated with hearing loss, Tinnitus, and Ménière's disease — restoring quality of life for millions worldwide.
Our novel device pathway focuses on the inflammatory mechanisms underlying these debilitating conditions.
Inflammation in the inner ear can damage delicate hair cells and neural pathways. Our approach targets these inflammatory processes to help preserve and protect auditory function.
Persistent ringing or buzzing affects millions of people daily. By addressing underlying auditory inflammation, we aim to reduce the severity and impact of tinnitus symptoms.
Episodes of vertigo, hearing loss, and tinnitus characterize this challenging condition. Our technology development focuses on the inflammatory components that drive these symptoms.
The scale of auditory health challenges is accelerating — and current solutions aren't keeping pace.
More than 430 million people worldwide suffer from disabling hearing loss today. Based on current trends, estimates project that by 2050, this number will exceed 711 million people requiring intervention — a crisis that demands new therapeutic approaches.
On top of that, as many as 1.4 billion of today's young people are at risk of permanent hearing loss from overexposure to loud environments and audio devices — a generation facing preventable auditory damage.
"Long-term exposure to sounds above 80 decibels can lead to permanent damage." At 100 decibels, even a few minutes can cause auditory inflammation and hearing loss.
Typical sound levels in everyday situations routinely exceed safe limits — increasing the risk of sensorineural hearing loss, or as we frame it, auditory inflammation leading to damage.
Rave-Bio is a Medtech development company dedicated to advancing auditory healthcare technologies. Our product development team has identified a novel device pathway with the potential to alleviate inflammation associated with hearing loss, Tinnitus, and Ménière's disease.
We are committed to bringing science-driven solutions to the millions of people who suffer from auditory inflammation-related conditions, with the goal of improving their daily lives and long-term hearing health.
Proprietary approach to auditory inflammation
Deep medtech development experience
Focused on quality of life outcomes
Structured device development pathway
Your daily routine — concerts, flights, headphones, gym classes — exposes your ears to more noise than you might think. Our 2-minute lifestyle assessment estimates how your cumulative sound exposure compares to normal age-related hearing decline, based on NIOSH guidelines.
Start Your Assessment8 quick questions. No sign-up required. Educational use only.
What we evaluate
Takes about 2 minutes
Whether you're a healthcare professional, potential partner, or investor, we'd love to hear from you. Reach out and a member of our team will respond promptly.